Cynomolgus_IL-31RA OSMR Reporter Baf3 Cell Line
Cat. No.
GM-C38785
Size
Quote
Description
Data display
Specifications
Materials
Related products
Cell Culture
Description
Cat. No: GM-C38785
Product: Cynomolgus_IL-31RA OSMR Reporter Baf3 Cell Line


Interleukin-31 (IL-31) is a novel cytokine belonging to the IL-6 cytokine family, primarily secreted by activated CD4+ T lymphocytes, especially Th2 cells, mast cells, macrophages, and dendritic cells. IL-31 regulates skin cell-mediated immunity by sensing itch in the nervous system, increases airway inflammation to modulate lung immunity, and influences gut immunity through microbial defense.

IL-31 signals through a heterodimer complex formed with IL31RA and OSMR. Its signaling pathway is closely associated with chronic itchy skin diseases such as atopic dermatitis. Monoclonal antibody drugs targeting IL-31 or its receptors can effectively reduce itching and sleep disturbances, improve skin lesions, and minimize the use of topical steroids.

Cynomolgus_IL-31RA OSMR Reporter Baf3 Cell Line is a clonal stable Baf3 cell line constructed using lentiviral technology, constitutive expression of the Cynomolgus IL31RA and OSMR, along with signal-dependent expression of a luciferase reporter gene. When IL-31 binds to IL-31RA and OSMR heterodimer, it activates downstream signaling pathways, leading to the expression of luciferase. Blockade antibodies can inhibit this signal transmission. The luciferase activity measurement indicates the activation level of the signaling pathway and can thus be used to evaluate the in vitro effects of drugs related to IL-31.
Data display
Response to Recombinant Cynomolgus IL31 Protein. The Cynomolgus_IL-31RA OSMR Reporter Baf3 Cell Line (Cat. GM-C38785) at a concentration of 1E5 cells/well (96-well format) was stimulated with serial dilutions of Recombinant Cynomolgus IL31 Protein (Sino Biological/90895-C08H) in assay buffer (RPMI 1640+1% FBS+1% P.S) for 6 hours. The firefly luciferase activity was measured using the GMOne-Step Luciferase Reporter Gene Assay Kit (Cat. GM-040503). The maximum induction fold was approximately [35.0]. Data are shown by drug mass concentration.
Response to Anti-IL31RA hIgG2 Antibody(Nemolizumab). Serial dilutions of the Anti-IL31RA hIgG2 Antibody(Nemolizumab) (Cat. GM-50871AB) was incubated with 1E5 cells/well of Cynomolgus_IL-31RA OSMR Reporter Baf3 Cell Line (Cat. GM-C38785) in a 96-well plate for 1 hour in assay buffer (RPMI 1640+1% FBS+1% P.S). Subsequently, the Recombinant Cynomolgus IL31 Protein (Sino Biological/90895-C08H) at a concentration of 0.2 ng/well was added, and the coculture proceeded for an additional 6 hours. Firefly luciferase activity is then measured using the GMOne-Step Luciferase Reporter Gene Assay Kit (Cat. GM-040503). The results indicated maximum blocking folds of approximately [7.8]. Data are shown by drug mass concentration.
Cynomolgus_IL-31RA OSMR Reporter Baf3 Cell Line (Cat. GM-C38785) was determined by flow cytometry using Anti-IL31RA hIgG2 Antibody(Nemolizumab) (Cat. GM-50871AB).
Cynomolgus_IL-31RA OSMR Reporter Baf3 Cell Line (Cat. GM-C38785) was determined by flow cytometry using Anti-OSMR hIgG4 Antibody(Vixarelimab) (Cat. GM-50874AB).
Specifications
Reagent Ordering Information
RPMI 1640 VivaCell/C3010-0500
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Recombinant Mouse IL-3 (C-6His) Novoprotein/CP39
Blasticidin Genomeditech/GM-040404
G418 Genomeditech/GM-040402
Puromycin Genomeditech/GM-040401
Recombinant Cynomolgus IL31 Protein;His Tag Sino Biological/90895-C08H
Anti-IL31RA hIgG2 Antibody Genomeditech/GM-50871AB
GMOne-Step Luciferase Reporter Gene Assay Kit Genomeditech/GM-040503
Materials
Reagent Ordering Information
RPMI 1640 VivaCell/C3010-0500
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Recombinant Mouse IL-3 (C-6His) Novoprotein/CP39
Blasticidin Genomeditech/GM-040404
G418 Genomeditech/GM-040402
Puromycin Genomeditech/GM-040401
Recombinant Cynomolgus IL31 Protein;His Tag Sino Biological/90895-C08H
Anti-IL31RA hIgG2 Antibody Genomeditech/GM-50871AB
GMOne-Step Luciferase Reporter Gene Assay Kit Genomeditech/GM-040503
Related products
OX40:OX40L
H_OX40 Reporter Cell Line H_OX40 Reporter DDX35TM Cell Line Cynomolgus_OX40L CHO-K1 Cell Line
H_OX40 CHO-K1 Cell Line H_OX40L CHO-K1 Cell Line H_OX40L HEK-293 Cell Line
Anti-H_OX40 hIgG2 Antibody Anti-OX40L hIgG1 Reference Antibody Anti-OX40L hIgG4 Antibody
Anti-OX40L hIgG4 Reference Antibody    
Biotinylated Human OX40L Protein; His-Avi Tag Cynomolgus OX40 Protein; His Tag Cynomolgus OX40L Protein; His Tag
Cynomolgus OX40L Protein; mFc Tag Human OX40 Protein; His Tag Human OX40L Protein; His Tag
Human OX40L Protein; mFc Tag    
IL-4/IL-13
IL-4 Reporter Cell Line IL-4/IL-13 Reporter 293 Cell Line IL-4/IL-13 Reporter 293 DDX35TM Cell Line
Cynomolgus_IL4R CHO-K1 Cell Line H_IL4R CHO-K1 Cell Line Mouse_IL4R CHO-K1 Cell Line
Anti-IL-4R hIgG1 Antibody(12B5) Anti-IL4R hIgG4 Antibody Anti-IL4R hIgG4 Reference Antibody
Biotinylated Human IL-4R alpha Protein; Avi-His Tag Cynomolgus IL-13 Protein; His Tag Cynomolgus IL-4R alpha Protein; His Tag
Human IL-13 Protein; His Tag Human IL-13RA1 Protein; His Tag Human IL-4 Protein; His Tag
Human IL-4R alpha Protein; hFc Tag Human IL-4R alpha Protein; His Tag Human IL-4R alpha Protein; mFc Tag
Mouse IL-13 Protein; His Tag Mouse IL-4R alpha Protein; His Tag Rat IL-4R alpha Protein; His Tag
IL-31
H_IL-31 Reporter Cell Line Cynomolgus_IL31RA CHO-K1 Cell Line H_IL31RA CHO-K1 Cell Line
H_IL31RA HEK-293 Cell Line H_IL-31RA OSMR Baf3 Cell Line  
Anti-IL31 hIgG1 Antibody(mAb33) Anti-IL31RA hIgG1 Antibody(NA633) Anti-IL31RA hIgG2 Antibody
Anti-OSMR hIgG4 Antibody    
Cynomolgus IL-31 Protein; His Tag Human IL-31 Protein; His Tag Human IL-31RA Protein; hFc Tag
MRGPRX2
H_MRGPRX2 Gqi5 Reporter CHO-K1 Cell Line Tango-H_MRGPRX2 CHO-K1 Cell Line Cynomolgus_MRGPRX2 CHO-K1 Cell Line
Cynomolgus_MRGPRX2 HEK-293 Cell Line Flag-Mouse_Mrgprb2 CHO-K1 Cell Line Flag-Rat_Mrgprb3 HEK-293 Cell Line
H_MRGPRX2 CHO-K1 Cell Line H_MRGPRX2 HEK-293 Cell Line H_MRGPRX2 HMC-1 Cell Line
H_MRGPRX2 RBL-2H3 Cell Line    
Cell Culture

Cell Recovery

Recovery Medium: RPMI 1640+10% FBS+1% P.S+8 ng/mL M_IL-3

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium. And spin at approximately 176 x g for 5 minutes.Discard supernatant.

d)       Resuspend cell pellet with the recommended complete medium. And dispense the suspension into 1-2 T-25 culture flasks.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vials in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: RPMI 1640+10% FBS+1% P.S+8 ng/mL M_IL-3+5 μg/mL Blasticidin+50 μg/mL G418+0.25 μg/mL Puromycin

Approximately 48-72 hours after the initial thawing, the cells can be passaged for the first time. After this initial passage, the culture medium can be adjusted to growth medium supplemented with antibiotics. If cells are not passaged within 48 hours, it is recommended to add some fresh recovery medium and place the flask horizontally.

a)          When the cell density reaches 1 - 1.2E6 cells/mL, subculture the cells. Do not allow the cell density to exceed 1.4E6 cells/mL.

b)         It is recommended to use T-25 flasks for subculturing.

c)          These cells are suspension cells, and it is recommended to use the "half-medium change" method to maintain optimal cell conditions during passaging.

d)         During passaging, you can directly add fresh growth medium to the culture flask, gently pipette to resuspend the cells, and then transfer the cell suspension to a new T-25 flask for continued culture.

Subcultivation Ratio: Maintain cultures at a cell concentraion between 3E5 and 1E6 viable cells/mL.

Medium Renewal: Every 2 to 3 days

Notes

a)          These cells are sensitive to density, so please ensure that the cell density is maintained within an appropriate range during culture and subculturing.

b)         During the first passage, pay attention to the nutrient supply; if not subculturing, make sure to add fresh recovery medium every other day as needed.


For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
Cynomolgus_IL-31RA OSMR Reporter Baf3 Cell Line
Cat. No.
GM-C38785
Size
Quote
Description
Data display
Specifications
Materials
Related products
Cell Culture
Description
Cat. No: GM-C38785
Product: Cynomolgus_IL-31RA OSMR Reporter Baf3 Cell Line


Interleukin-31 (IL-31) is a novel cytokine belonging to the IL-6 cytokine family, primarily secreted by activated CD4+ T lymphocytes, especially Th2 cells, mast cells, macrophages, and dendritic cells. IL-31 regulates skin cell-mediated immunity by sensing itch in the nervous system, increases airway inflammation to modulate lung immunity, and influences gut immunity through microbial defense.

IL-31 signals through a heterodimer complex formed with IL31RA and OSMR. Its signaling pathway is closely associated with chronic itchy skin diseases such as atopic dermatitis. Monoclonal antibody drugs targeting IL-31 or its receptors can effectively reduce itching and sleep disturbances, improve skin lesions, and minimize the use of topical steroids.

Cynomolgus_IL-31RA OSMR Reporter Baf3 Cell Line is a clonal stable Baf3 cell line constructed using lentiviral technology, constitutive expression of the Cynomolgus IL31RA and OSMR, along with signal-dependent expression of a luciferase reporter gene. When IL-31 binds to IL-31RA and OSMR heterodimer, it activates downstream signaling pathways, leading to the expression of luciferase. Blockade antibodies can inhibit this signal transmission. The luciferase activity measurement indicates the activation level of the signaling pathway and can thus be used to evaluate the in vitro effects of drugs related to IL-31.
Cat. No: GM-C38785
Product: Cynomolgus_IL-31RA OSMR Reporter Baf3 Cell Line


Interleukin-31 (IL-31) is a novel cytokine belonging to the IL-6 cytokine family, primarily secreted by activated CD4+ T lymphocytes, especially Th2 cells, mast cells, macrophages, and dendritic cells. IL-31 regulates skin cell-mediated immunity by sensing itch in the nervous system, increases airway inflammation to modulate lung immunity, and influences gut immunity through microbial defense.

IL-31 signals through a heterodimer complex formed with IL31RA and OSMR. Its signaling pathway is closely associated with chronic itchy skin diseases such as atopic dermatitis. Monoclonal antibody drugs targeting IL-31 or its receptors can effectively reduce itching and sleep disturbances, improve skin lesions, and minimize the use of topical steroids.

Cynomolgus_IL-31RA OSMR Reporter Baf3 Cell Line is a clonal stable Baf3 cell line constructed using lentiviral technology, constitutive expression of the Cynomolgus IL31RA and OSMR, along with signal-dependent expression of a luciferase reporter gene. When IL-31 binds to IL-31RA and OSMR heterodimer, it activates downstream signaling pathways, leading to the expression of luciferase. Blockade antibodies can inhibit this signal transmission. The luciferase activity measurement indicates the activation level of the signaling pathway and can thus be used to evaluate the in vitro effects of drugs related to IL-31.
Data display
Response to Recombinant Cynomolgus IL31 Protein. The Cynomolgus_IL-31RA OSMR Reporter Baf3 Cell Line (Cat. GM-C38785) at a concentration of 1E5 cells/well (96-well format) was stimulated with serial dilutions of Recombinant Cynomolgus IL31 Protein (Sino Biological/90895-C08H) in assay buffer (RPMI 1640+1% FBS+1% P.S) for 6 hours. The firefly luciferase activity was measured using the GMOne-Step Luciferase Reporter Gene Assay Kit (Cat. GM-040503). The maximum induction fold was approximately [35.0]. Data are shown by drug mass concentration.
Response to Anti-IL31RA hIgG2 Antibody(Nemolizumab). Serial dilutions of the Anti-IL31RA hIgG2 Antibody(Nemolizumab) (Cat. GM-50871AB) was incubated with 1E5 cells/well of Cynomolgus_IL-31RA OSMR Reporter Baf3 Cell Line (Cat. GM-C38785) in a 96-well plate for 1 hour in assay buffer (RPMI 1640+1% FBS+1% P.S). Subsequently, the Recombinant Cynomolgus IL31 Protein (Sino Biological/90895-C08H) at a concentration of 0.2 ng/well was added, and the coculture proceeded for an additional 6 hours. Firefly luciferase activity is then measured using the GMOne-Step Luciferase Reporter Gene Assay Kit (Cat. GM-040503). The results indicated maximum blocking folds of approximately [7.8]. Data are shown by drug mass concentration.
Cynomolgus_IL-31RA OSMR Reporter Baf3 Cell Line (Cat. GM-C38785) was determined by flow cytometry using Anti-IL31RA hIgG2 Antibody(Nemolizumab) (Cat. GM-50871AB).
Cynomolgus_IL-31RA OSMR Reporter Baf3 Cell Line (Cat. GM-C38785) was determined by flow cytometry using Anti-OSMR hIgG4 Antibody(Vixarelimab) (Cat. GM-50874AB).
Specifications
Reagent Ordering Information
RPMI 1640 VivaCell/C3010-0500
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Recombinant Mouse IL-3 (C-6His) Novoprotein/CP39
Blasticidin Genomeditech/GM-040404
G418 Genomeditech/GM-040402
Puromycin Genomeditech/GM-040401
Recombinant Cynomolgus IL31 Protein;His Tag Sino Biological/90895-C08H
Anti-IL31RA hIgG2 Antibody Genomeditech/GM-50871AB
GMOne-Step Luciferase Reporter Gene Assay Kit Genomeditech/GM-040503
Reagent Ordering Information
RPMI 1640 VivaCell/C3010-0500
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Recombinant Mouse IL-3 (C-6His) Novoprotein/CP39
Blasticidin Genomeditech/GM-040404
G418 Genomeditech/GM-040402
Puromycin Genomeditech/GM-040401
Recombinant Cynomolgus IL31 Protein;His Tag Sino Biological/90895-C08H
Anti-IL31RA hIgG2 Antibody Genomeditech/GM-50871AB
GMOne-Step Luciferase Reporter Gene Assay Kit Genomeditech/GM-040503
Materials
Reagent Ordering Information
RPMI 1640 VivaCell/C3010-0500
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Recombinant Mouse IL-3 (C-6His) Novoprotein/CP39
Blasticidin Genomeditech/GM-040404
G418 Genomeditech/GM-040402
Puromycin Genomeditech/GM-040401
Recombinant Cynomolgus IL31 Protein;His Tag Sino Biological/90895-C08H
Anti-IL31RA hIgG2 Antibody Genomeditech/GM-50871AB
GMOne-Step Luciferase Reporter Gene Assay Kit Genomeditech/GM-040503
Reagent Ordering Information
RPMI 1640 VivaCell/C3010-0500
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Recombinant Mouse IL-3 (C-6His) Novoprotein/CP39
Blasticidin Genomeditech/GM-040404
G418 Genomeditech/GM-040402
Puromycin Genomeditech/GM-040401
Recombinant Cynomolgus IL31 Protein;His Tag Sino Biological/90895-C08H
Anti-IL31RA hIgG2 Antibody Genomeditech/GM-50871AB
GMOne-Step Luciferase Reporter Gene Assay Kit Genomeditech/GM-040503
Related products
OX40:OX40L
H_OX40 Reporter Cell Line H_OX40 Reporter DDX35TM Cell Line Cynomolgus_OX40L CHO-K1 Cell Line
H_OX40 CHO-K1 Cell Line H_OX40L CHO-K1 Cell Line H_OX40L HEK-293 Cell Line
Anti-H_OX40 hIgG2 Antibody Anti-OX40L hIgG1 Reference Antibody Anti-OX40L hIgG4 Antibody
Anti-OX40L hIgG4 Reference Antibody    
Biotinylated Human OX40L Protein; His-Avi Tag Cynomolgus OX40 Protein; His Tag Cynomolgus OX40L Protein; His Tag
Cynomolgus OX40L Protein; mFc Tag Human OX40 Protein; His Tag Human OX40L Protein; His Tag
Human OX40L Protein; mFc Tag    
IL-4/IL-13
IL-4 Reporter Cell Line IL-4/IL-13 Reporter 293 Cell Line IL-4/IL-13 Reporter 293 DDX35TM Cell Line
Cynomolgus_IL4R CHO-K1 Cell Line H_IL4R CHO-K1 Cell Line Mouse_IL4R CHO-K1 Cell Line
Anti-IL-4R hIgG1 Antibody(12B5) Anti-IL4R hIgG4 Antibody Anti-IL4R hIgG4 Reference Antibody
Biotinylated Human IL-4R alpha Protein; Avi-His Tag Cynomolgus IL-13 Protein; His Tag Cynomolgus IL-4R alpha Protein; His Tag
Human IL-13 Protein; His Tag Human IL-13RA1 Protein; His Tag Human IL-4 Protein; His Tag
Human IL-4R alpha Protein; hFc Tag Human IL-4R alpha Protein; His Tag Human IL-4R alpha Protein; mFc Tag
Mouse IL-13 Protein; His Tag Mouse IL-4R alpha Protein; His Tag Rat IL-4R alpha Protein; His Tag
IL-31
H_IL-31 Reporter Cell Line Cynomolgus_IL31RA CHO-K1 Cell Line H_IL31RA CHO-K1 Cell Line
H_IL31RA HEK-293 Cell Line H_IL-31RA OSMR Baf3 Cell Line  
Anti-IL31 hIgG1 Antibody(mAb33) Anti-IL31RA hIgG1 Antibody(NA633) Anti-IL31RA hIgG2 Antibody
Anti-OSMR hIgG4 Antibody    
Cynomolgus IL-31 Protein; His Tag Human IL-31 Protein; His Tag Human IL-31RA Protein; hFc Tag
MRGPRX2
H_MRGPRX2 Gqi5 Reporter CHO-K1 Cell Line Tango-H_MRGPRX2 CHO-K1 Cell Line Cynomolgus_MRGPRX2 CHO-K1 Cell Line
Cynomolgus_MRGPRX2 HEK-293 Cell Line Flag-Mouse_Mrgprb2 CHO-K1 Cell Line Flag-Rat_Mrgprb3 HEK-293 Cell Line
H_MRGPRX2 CHO-K1 Cell Line H_MRGPRX2 HEK-293 Cell Line H_MRGPRX2 HMC-1 Cell Line
H_MRGPRX2 RBL-2H3 Cell Line    
Cell Culture

Cell Recovery

Recovery Medium: RPMI 1640+10% FBS+1% P.S+8 ng/mL M_IL-3

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium. And spin at approximately 176 x g for 5 minutes.Discard supernatant.

d)       Resuspend cell pellet with the recommended complete medium. And dispense the suspension into 1-2 T-25 culture flasks.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vials in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: RPMI 1640+10% FBS+1% P.S+8 ng/mL M_IL-3+5 μg/mL Blasticidin+50 μg/mL G418+0.25 μg/mL Puromycin

Approximately 48-72 hours after the initial thawing, the cells can be passaged for the first time. After this initial passage, the culture medium can be adjusted to growth medium supplemented with antibiotics. If cells are not passaged within 48 hours, it is recommended to add some fresh recovery medium and place the flask horizontally.

a)          When the cell density reaches 1 - 1.2E6 cells/mL, subculture the cells. Do not allow the cell density to exceed 1.4E6 cells/mL.

b)         It is recommended to use T-25 flasks for subculturing.

c)          These cells are suspension cells, and it is recommended to use the "half-medium change" method to maintain optimal cell conditions during passaging.

d)         During passaging, you can directly add fresh growth medium to the culture flask, gently pipette to resuspend the cells, and then transfer the cell suspension to a new T-25 flask for continued culture.

Subcultivation Ratio: Maintain cultures at a cell concentraion between 3E5 and 1E6 viable cells/mL.

Medium Renewal: Every 2 to 3 days

Notes

a)          These cells are sensitive to density, so please ensure that the cell density is maintained within an appropriate range during culture and subculturing.

b)         During the first passage, pay attention to the nutrient supply; if not subculturing, make sure to add fresh recovery medium every other day as needed.


Cell Recovery

Recovery Medium: RPMI 1640+10% FBS+1% P.S+8 ng/mL M_IL-3

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium. And spin at approximately 176 x g for 5 minutes.Discard supernatant.

d)       Resuspend cell pellet with the recommended complete medium. And dispense the suspension into 1-2 T-25 culture flasks.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vials in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: RPMI 1640+10% FBS+1% P.S+8 ng/mL M_IL-3+5 μg/mL Blasticidin+50 μg/mL G418+0.25 μg/mL Puromycin

Approximately 48-72 hours after the initial thawing, the cells can be passaged for the first time. After this initial passage, the culture medium can be adjusted to growth medium supplemented with antibiotics. If cells are not passaged within 48 hours, it is recommended to add some fresh recovery medium and place the flask horizontally.

a)          When the cell density reaches 1 - 1.2E6 cells/mL, subculture the cells. Do not allow the cell density to exceed 1.4E6 cells/mL.

b)         It is recommended to use T-25 flasks for subculturing.

c)          These cells are suspension cells, and it is recommended to use the "half-medium change" method to maintain optimal cell conditions during passaging.

d)         During passaging, you can directly add fresh growth medium to the culture flask, gently pipette to resuspend the cells, and then transfer the cell suspension to a new T-25 flask for continued culture.

Subcultivation Ratio: Maintain cultures at a cell concentraion between 3E5 and 1E6 viable cells/mL.

Medium Renewal: Every 2 to 3 days

Notes

a)          These cells are sensitive to density, so please ensure that the cell density is maintained within an appropriate range during culture and subculturing.

b)         During the first passage, pay attention to the nutrient supply; if not subculturing, make sure to add fresh recovery medium every other day as needed.


Message consultation
reset
submit
Message
Message consultation
reset
submit